VERACYTE, INC. Uncategorized Contracts & Agreements

19 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Veracyte, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
VERACYTE, INC.
Biotechnology
2025
Veracyte Offer Letter for Chief Medical Officer & Chief Scientific Officer – Phil Febbo
Employment Agreements
VERACYTE, INC.
Biotechnology
2024
Veracyte Promotion and Compensation Adjustment Letter for John Leite (Chief Commercial Officer, CLIA)
Compensation Agreements
VERACYTE, INC.
Biotechnology
2024
Description of Veracyte, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
VERACYTE, INC.
Biotechnology
2024
Advisory Services Agreement between Veracyte, Inc. and Tina Nova, PhD
Advisory Agreements
VERACYTE, INC.
Biotechnology
2023
Veracyte Promotion Offer Letter for Ann McGuire as General Counsel and Chief People Officer
Employment Agreements
VERACYTE, INC.
Biotechnology
2023
Veracyte Offer Letter of Employment for Annie McGuire as SVP, General Counsel
Employment Agreements
VERACYTE, INC.
Biotechnology
2022
Veracyte, Inc. Offer Letter to Tina S. Nova, PhD (General Manager, Urological Cancers)
Employment Agreements
VERACYTE, INC.
Biotechnology
DE
2022
Veracyte Offer Letter of Employment to Rebecca Chambers as Chief Financial Officer (Amended)
Employment Agreements
VERACYTE, INC.
Biotechnology
2021
Veracyte Executive Employment Offer Letter to James H. Erlinger III (EVP, General Counsel)
Employment Agreements
VERACYTE, INC.
Biotechnology
2021
Veracyte Employment Offer Letter to John Hanna for Director of Global Health Care Policy & Governmental Affairs
Employment Agreements
VERACYTE, INC.
Biotechnology
2020
Veracyte, Inc. Employment Offer Letter to Giulia Kennedy for Senior Vice President, R&D Position
Employment Agreements
VERACYTE, INC.
Biotechnology
2020
Agreement dated as of October 16, 2017, between Thyroid Cytopathology Partners, P.A. and the Registrant, as amended
VERACYTE, INC.
Biotechnology
TX
2019
Veracyte Offer Letter of Employment for Chief Financial Officer (Keith Kennedy)
Employment Agreements
VERACYTE, INC.
Biotechnology
2018
Ex-U.S. Co-Promotion Agreement between Genzyme Corporation and Veracyte, Inc.
Collaboration Agreements
VERACYTE, INC.
Biotechnology
NY
2015
Amended and Restated U.S. Co-Promotion Agreement between Genzyme Corporation and Veracyte, Inc.
Collaboration Agreements
VERACYTE, INC.
Biotechnology
NY
2014
Description of Veracyte, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
VERACYTE, INC.
Biotechnology
2021
Description of Veracyte, Inc. Capital Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
VERACYTE, INC.
Biotechnology
2020
Letter Agreement for Proposed Second Amendment to Co-Promotion Agreement between Veracyte, Inc. and Genzyme Corporation
Modification Agreements
VERACYTE, INC.
Biotechnology
2014